A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer

NCT01586611 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

175

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreas Cancer

Interventions

DRUG: 5FU, leucovorin, oxaliplatin
DRUG: Gemcitabine

Sponsor

AHS Cancer Control Alberta